Monday, March 20, 2006

Provigil by another name

Cephalon wants the FDA to approve its narcolepsy drug modafanil (also known as Provigil) for ADHD. Why? Because the patent has expired; they have paid generic manufacturers not to make it; and approval for pediatric use will give Cephalon six more months of exclusivity. Merrill Goozner of the Center for Science in the Public Interest blogs the story in "Pawns in Their Game."

No comments: